Dapagliflozin + Saxagliptin in a Basal-bolus Insulin Treatment
Condition(s):Type 2 DiabetesLast Updated:February 11, 2020Terminated
Hide Studies Not Open or Pending
Condition(s):Type 2 DiabetesLast Updated:February 11, 2020Terminated
Condition(s):Chronic Back PainLast Updated:January 9, 2020Withdrawn
Condition(s):Multiple Sclerosis, Relapsing RemittingLast Updated:February 28, 2018Completed
Condition(s):Acne Vulgaris; AcneLast Updated:January 24, 2024Completed
Condition(s):Major Depressive Disorder Without Psychotic FeaturesLast Updated:October 1, 2015Completed
Condition(s):Critical Limb IschemiaLast Updated:March 13, 2020Unknown status
Condition(s):Diabetes Mellitus; Critical Limb Ischemia; Lower Limb Amputation Knee; Peripheral Arterial DiseaseLast Updated:April 12, 2022Suspended
Condition(s):PsoriasisLast Updated:October 30, 2018Completed
Condition(s):Insulin Resistance; Nutritional Disease; Metabolic DiseaseLast Updated:February 8, 2023Completed
Condition(s):AgingLast Updated:February 2, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.